AR038666A1 - Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y un acido 4-oxobutanoico y uso de la misma para el tratamiento de la diabetes - Google Patents

Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y un acido 4-oxobutanoico y uso de la misma para el tratamiento de la diabetes

Info

Publication number
AR038666A1
AR038666A1 ARP020105117A ARP020105117A AR038666A1 AR 038666 A1 AR038666 A1 AR 038666A1 AR P020105117 A ARP020105117 A AR P020105117A AR P020105117 A ARP020105117 A AR P020105117A AR 038666 A1 AR038666 A1 AR 038666A1
Authority
AR
Argentina
Prior art keywords
diabetes
treatment
pharmaceutical composition
alfa
oxobutanoic acid
Prior art date
Application number
ARP020105117A
Other languages
English (en)
Inventor
Moinet Gerard Dr
Dominique Marais
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR038666A1 publication Critical patent/AR038666A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composición farmacéutica que comprende, como principios activos, un ácido 4-oxobutanoico y un inhibidor de alfa-glucosidasa, en combinación con uno o varios excipientes aceptables para uso farmacéutico. Estas composiciones son particularmente adecuadas para el tratamiento de la diabetes.
ARP020105117A 2001-12-28 2002-12-27 Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y un acido 4-oxobutanoico y uso de la misma para el tratamiento de la diabetes AR038666A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0117041A FR2834214B1 (fr) 2001-12-28 2001-12-28 Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete

Publications (1)

Publication Number Publication Date
AR038666A1 true AR038666A1 (es) 2005-01-26

Family

ID=8871080

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020105117A AR038666A1 (es) 2001-12-28 2002-12-27 Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y un acido 4-oxobutanoico y uso de la misma para el tratamiento de la diabetes

Country Status (16)

Country Link
US (1) US20050070553A1 (es)
EP (1) EP1458412A1 (es)
JP (1) JP2005513149A (es)
KR (1) KR20040075871A (es)
CN (1) CN1633304A (es)
AR (1) AR038666A1 (es)
AU (1) AU2002358641A1 (es)
BR (1) BR0215352A (es)
CA (1) CA2471635A1 (es)
FR (1) FR2834214B1 (es)
HU (1) HUP0600455A2 (es)
MX (1) MXPA04006269A (es)
PL (1) PL369854A1 (es)
RU (1) RU2004123253A (es)
WO (1) WO2003055523A1 (es)
ZA (1) ZA200405987B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070102694A (ko) * 2005-01-31 2007-10-19 아지노모토 가부시키가이샤 혈당 강하제를 함유하는, 내당능 이상, 경계형 당뇨병,인슐린 저항성 및 고인슐린혈증 개선 또는 치료용 의약조성물
TR201100148A2 (tr) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Stabil akarboz förmülasyonları.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3543999A1 (de) * 1985-12-13 1987-06-19 Bayer Ag Hochreine acarbose
JP3580900B2 (ja) * 1995-04-20 2004-10-27 ホクレン農業協同組合連合会 α−グルコシダーゼ阻害剤を含む糖を主体とする組成物を有効成分とする食品及び飼料
DE69523182T2 (de) * 1995-06-06 2002-02-07 Pfizer Substituierte n-(indol-2-carbonyl)-glycinamide und derivate als glycogen phosphorylase inhibitoren
US5863915A (en) * 1996-05-15 1999-01-26 Bayer Corporation Substituted 4-arylbutyric acid derivatives as matrix metalloprotease
FR2752422B1 (fr) * 1996-08-16 1998-11-06 Lipha Composition pharmaceutique contenant des acides 4-oxo-butanoiques
GB9922710D0 (en) * 1999-09-24 1999-11-24 Bayer Ag Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis

Also Published As

Publication number Publication date
EP1458412A1 (en) 2004-09-22
HUP0600455A2 (en) 2006-09-28
ZA200405987B (en) 2005-09-28
RU2004123253A (ru) 2005-06-10
WO2003055523A1 (en) 2003-07-10
CN1633304A (zh) 2005-06-29
PL369854A1 (en) 2005-05-02
FR2834214A1 (fr) 2003-07-04
KR20040075871A (ko) 2004-08-30
AU2002358641A1 (en) 2003-07-15
FR2834214B1 (fr) 2004-09-24
JP2005513149A (ja) 2005-05-12
BR0215352A (pt) 2004-12-14
MXPA04006269A (es) 2004-09-27
US20050070553A1 (en) 2005-03-31
CA2471635A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
GT200900154A (es) Derivados de 2,3-dihidroimidozo [1,2-c] quinizolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
ATE254928T1 (de) Stabilisierte zusammensetzung mit nootropen wirkstoffen
AR043985A1 (es) Tratamiento terapeutico de la constipacion
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
BR0313343A (pt) Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
HRP20040059B1 (en) Treatment of nail infections with no
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
ATE275393T1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
FI964285A (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
BR0111678A (pt) Composições medicinais contendo derivados de propenona
AR052048A1 (es) Composiciones farmaceuticas para el tratamiento de la celulitis
ITMI20052515A1 (it) Formulazione farmaceutica per il trattamento della osteoartrite
AR047880A1 (es) COMBINACIoN DE UN INHIBIDOR DE RENINA Y DIURÉTICOS
DK0917460T3 (da) Cyclosporin-formulering
AR038666A1 (es) Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y un acido 4-oxobutanoico y uso de la misma para el tratamiento de la diabetes
ECSP003859A (es) Composicion para el tratamiento de tejidos dañados
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
AR037496A1 (es) Uso novedoso del 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y sus sales fisiologicamente aceptables
ES2421520T3 (es) Potenciador de la producción de adiponectina
RS50074B (sr) Farmaceutski preparat koji sadrži paracetamol i drotaverin
BR0215498A (pt) Composição farmacêutica compreendendo uma glitazona e um ácido 4-oxobutanóico e o seu uso para o tratamento de diabetes
IL172675A0 (en) Benzofuran derivatives and their use in the treatment of microbial infections

Legal Events

Date Code Title Description
FB Suspension of granting procedure